NOX4-dependent hydrogen peroxide overproduction in human atrial fibrillation and HL-1 atrial cells: Relationship to hypertension

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Zhang, Jun ^a   Youn, Ji Youn ^a   Kim, Antony Y ^b   Ramirez, Rafael J ^a   Gao, Ling ^a   Ngo, Doan ^a   Chen, Peng ^a   Scovotti, Jennifer ^a   Mahajan, Aman ^a   Cai, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Angiotensin II; Atrial fibrillation; HL 1 cells; Hydrogen peroxide; Hypertension; NADPH oxidase; Nox4

Indexed keywords

EID: 84866325854     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00140     Document Type: Article

References (55)

1. Ago, T., Kitazono, T., Kuroda, J., Kumai, Y., Kamouchi, M., Ooboshi, H., Wak-isaka, M., Kawahara, T., Rokutan, K., Ibayashi, S., and Iida, M. (2005). NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36, 1040-1046.
2. Ago, T., Kitazono, T., Ooboshi, H., Iyama, T., Han, Y. H., Takada, J., Wakisaka, M., Ibayashi, S., Utsumi, H., and Iida, M. (2004) Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109, 227-233.
3. Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., and Sadoshima, J. (2010). Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 106, 1253-1264.
4. 2+ and cell death during ischaemia-reperfusion injury in car-diomyocytes. J. Physiol (Lond.) 587, 1331-1341.
5. Block, K., Gorin, Y., and Abboud, H. E. (2009). Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl. Acad. Sci. U.S.A. 106, 14385-14390.
6. Bonello, S., Zahringer, C., BelAiba, R. S., Djordjevic, T., Hess, J., Michiels, C., Kietzmann, T., and Gorlach, A. (2007). Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler. Thromb. Vasc. Biol. 27, 755-761.
7. Brady, N. R., Hamacher-Brady, A., and Gottlieb, R. A. (2006). Proapop-totic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim. Biophys. Acta 1757, 667-678.
8. Byrne, J. A., Grieve, D. J., Bendall, J. K., Li, J. M., Gove, C., Lambeth, J. D., Cave, A. C., and Shah, A. M. (2003). Contrasting roles of NADPH oxi-dase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93, 802-805.
9. Cai, H. (2005a). Hydrogen peroxide regulation of endothelial function: mechanisms, consequences and origins. Cardiovasc. Res. 68, 26-36.
10. Cai, H. (2005b). NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ. Res. 96, 818-822.
11. Cai, H., Griendling, K. K., and Harrison, D. G. (2003). The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24, 471-478.
12. Cai, H., and Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844.
13. Caouette, D., Dongmo, C., Berube, J., Fournier, D., and Daleau, P. (2003). Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line. Naunyn Schmiedebergs Arch. Pharmacol. 368, 479-486.
14. Chabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., Welch, W. J., and Wilcox, C. S. (2002). Expression and cellular localization of classic NADPH oxi-dase subunits in the spontaneously hypertensive rat kidney. Hypertension 39, 269-274.
15. Chalupsky, K., and Cai, H. (2005). Endothelial dihydrofolate reductase: critical for nitric oxide bioavailabil-ity and role in angiotensin II uncoupling of endothelial nitric oxide syn-thase. Proc. Natl. Acad. Sci. U.S.A. 102,9056-9061.
16. Chen, K., Kirber, M. T., Xiao, H., Yang, Y., and Keaney, J. F. Jr. (2008). Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 181,1129-1139.
17. Choi, H., Leto, T. L., Hunyady, L., Catt, K. J., Bae, Y S., and Rhee, S. G. (2008). Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase. J. Biol. Chem. 283,255-267.
18. Chou, C. C., and Chen, P. S. (2009). New concepts in atrial fibrillation: neural mechanisms and calcium dynamics. Cardiol. Clin. 27, 35-33.
19. Claycomb, W. C., Lanson, N. A. Jr., Stall-worth, B. S., Egeland, D. B., Delcar-pio, J. B., Bahinski, A., and Izzo, N. J. Jr. (1998). HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U.S.A. 95, 2979-2984.
20. Clempus, R. E., Sorescu, D., Dikalova, A. E., Pounkova, L., Jo, P., Sorescu, G. P., Schmidt, H. H., Lassegue, B., and Griendling, K. K. (2007). Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27, 42-48.
21. Everett, T. H., and Olgin, J. E. (2007). Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4, S24-S27.
22. Gao, L., Chalupsky, K., Stefani, E., and Cai, H. (2009a). Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice. A Novel HPLC-based Fluorescent Assay for DHFR Activity.J. Mol. Cell. Cardiol. 47, 752-760.
23. Gao, L., Pung, Y F., Zhang, J., Chen, P., Wang, T., Li, M., Meza, M., Toro, L., and Cai, H. (2009b). Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. Am. J. Physiol. Heart Circ. Physiol. 297, H331-H339.
24. Healey, J. S., Baranchuk, A., Crystal, E., Morillo, C. A., Garfinkle, M., Yusuf, S., and Connolly, S. J. (2005). Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J. Am. Coll. Cardiol. 45, 1832-1839.
25. Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., and Thannickal, V. J. (2009). NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 15, 1077-1081.
26. Ismail, S., Sturrock, A., Wu, P., Cahill, B., Norman, K., Huecksteadt, T., Sanders, K., Kennedy, T., and Hoidal, J. (2009). NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L489-L499.
27. Kannel, W B., Wolf, P. A., Benjamin, E. J., and Levy, D. (1998). Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol. 82,2N-9N.
28. Kim, Y H., Lee, J. H., Lim do, S., Shim, W J., Ro, Y M., Park, G. H., Becker, K. G., Cho-Chung, Y S., and Kim, M. K. (2003). Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp. Mol. Med. 35, 336-349.
29. Kim, Y M., Guzik, T. J., Zhang, Y. H., Zhang, M. H., Kattach, H., Ratnatunga, C., Pillai, R., Chan-non, K. M., and Casadei, B. (2005). A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ. Res. 97, 629-636.
30. Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., and Sadoshima, J. (2010). NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. U.S.A. 107, 15565-15570.
31. Lambeth, J. D., Kawahara, T., and Diebold, B. (2007). Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43, 319-331.
32. Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., and Harrison, D. G. (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209.
33. Lassegue, B., and Griendling, K. K. (2010). NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30, 653-661.
34. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., and Griendling, K. K. (2001). Novel gp91(phox) homo-logues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88, 888-894.
35. Lin, Y K., Lin, F. Z., Chen, Y .C., Cheng, C. C., Lin, C. I., Chen, Y. J., and Chen, S. A. (2010). Oxidative stress on pulmonary vein and left atrium arrhythmogenesis. Circ. J. 74,1547-1556.
36. Lu, G., Sun, H., Korge, P., Koehler, C. M., Weiss, J. N., and Wang, Y. (2009). Functional characterization of a mitochondrial Ser/Thr protein phosphatase in cell death regulation. Meth. Enzymol. 457,255-273.
37. Mace, L. C., Yermalitskaya, L. V., Yi, Y., Yang, Z., Morgan, A. M., and Murray, K. T. (2009). Transcrip-tional remodeling of rapidly stimulated HL-1 atrial myocytes exhibits concordance with human atrial fibrillation. J. Mol. Cell. Cardiol. 47, 485-492.
38. Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., and Knaus, U. G. (2006). Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell. Signal. 18, 69-82.
39. Morita, N., Sovari, A. A., Xie, Y., Fishbein, M. C., Mandel, W J., Garfinkel, A., Lin, S. F., Chen, P. S., Xie, L. H., Chen, F., Qu, Z., Weiss, J. N., and Karagueuzian, H. S. (2009). Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am. I Physiol. Heart Circ. Physiol. 297, H1594-H1605.
40. Nakashima, H., Kumagai, K., Urata, H., Gondo, N., Ideishi, M., and Arakawa, K. (2000). Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101, 2612-2617.
41. Oak, J. H., and Cai, H. (2007). Attenuation of angiotensin II signaling recouples eNOS and inhibits nonen-dothelial NOX activity in diabetic mice. Diabetes 56, 118-126.
42. Rodriguez-Sinovas, A., Garcia-Dorado, D., Pina, P., Ruiz-Meana, M., and Soler-Soler, J. (2005). Effect of sar-colemmal rupture on myocardial electrical impedance during oxygen deprivation. Am. J. Physiol. Heart Circ. Physiol. 288, H1396-H1403.
43. Savelieva, I., and Camm, J. (2008). Update on atrial fibrillation: part I. Clin. Cardiol. 31, 55-62.
44. Schroder, K., Wandzioch, K., Helm-cke, I., and Brandes, R. P. (2009). Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler. Thromb. Vasc. Biol. 29, 239-245.
45. Serrander, L., Cartier, L., Bedard, K., Banfi, B., Lardy, B., Plastre, O., Sienkiewicz, A., Forro, L., Schlegel, W., and Krause, K. H. (2007). NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem. J. 406, 105-114.
46. Shiose, A., Kuroda, J., Tsuruya, K., Hirai, M., Hirakata, H., Naito, S., Hat-tori, M., Sakaki, Y., and Sumimoto, H. (2001). A novel superoxide-producingNAD(P)H oxidase in kidney. J. Biol. Chem. 276,1417-1423.
47. Sturrock, A., Huecksteadt, T. P., Norman, K., Sanders, K., Murphy, T. M., Chitano, P., Wilson, K., Hoidal, J. R., and Kennedy, T. P. (2007). Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 292, L1543-L1555.
48. Tan, A. Y., and Zimetbaum, P. (2011). Atrial fibrillation and atrial fibro-sis. J. Cardiovasc. Pharmacol. 57, 625-629.
49. Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., and Schiffrin, E. L. (2002). Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ.Res. 90, 1205-1213.
50. Tsai, C. T., Lai, L. P., Hwang, J. J., Chen, W. P., Chiang, E T., Hsu, K. L., Tseng, C. D., Tseng, Y. Z., and Lin, J. L. (2008). Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation. J. Hypertens. 26, 570-582.
51. Tsai, C. T., Wang, D. L., Chen, W P., Hwang, J. J., Hsieh, C. S., Hsu, K. L., Tseng, C. D., Lai, L. P., Tseng, Y. Z., Chiang, E T., and Lin, J. L. (2007). Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathwayinHL-1 myocytes. Circ. Res. 100,1476-1485.
52. White, S. M., Constantin, P. E., and Claycomb, W C. (2004). Cardiac physiology at the cellular level: use of cultured HL-1 cardiomy-ocytes for studies of cardiac muscle cell structure and function. Am. I Physiol. Heart Circ. Physiol. 286, H823-H829.
53. Wingler, K., Wunsch, S., Kreutz, R., Rothermund, L., Paul, M., and Schmidt, H.H. (2001).Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31, 1456-1464.
54. 2. Am. I Physiol. Cell Physiol. 296, C711-C723.
55. Zografos, T., and Katritsis, D. G. (2010). Inhibition of the renin-angiotensin system for prevention of atrial fibrillation. Pacing Clin. Electrophysiol. 33, 1270-1285.